L’Afrique face à l’industrie pharmaceutique (notice n° 735696)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01687cam a2200265 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250123085748.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Atchadé, Félix |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | L’Afrique face à l’industrie pharmaceutique |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2024.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 55 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | En Afrique, à ce jour, la pandémie de la Covid-19 n’a pas la même expression épidémiologique que dans les pays européens ou d’Amérique. Si l’impact en ce qui concerne la mortalité et la morbidité est moindre, les conséquences socioéconomiques sont d’un autre ordre. La crise a réitéré le constat que les promesses d’une juste distribution mondiale des produits pharmaceutiques ne sont pas tenues. L’accès aux médicaments a encore d’énormes progrès à faire pour se matérialiser en Afrique. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | To date, the Covid-19 pandemic in Africa does not have the same epidemiological expression as in European or American countries. While the impact in terms of mortality and morbidity is less, the socio-economic consequences are of a different order. The crisis has reiterated the fact that promises of fair global distribution of pharmaceuticals are not being kept. Access to medicines still has a long way to go to materialize in Africa. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | accès aux médicaments |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Afrique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | firmes pharmaceutiques |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Access to medicines |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Big Pharma |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Africa |
| 786 0# - DATA SOURCE ENTRY | |
| Note | La Pensée | 417 | 1 | 2024-03-18 | p. 119-127 | 0031-4773 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-la-pensee-2024-1-page-119?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-la-pensee-2024-1-page-119?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux